{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:11:45Z","timestamp":1792793505776,"version":"4.5.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare febrile disorder with multisystem organ involvement temporally associated with coronavirus 2019 infection (COVID-19) and frequently exhibits features mimicking Kawasaki disease (KD), another febrile disorder in children. The pathogenesis and the full clinical spectrum of MIS-C is poorly understood: It is still unclear whether MIS-C and KD are different syndromes or represent a common spectrum. The erythema and induration of Bacillus Calmette-Gu\u00e9rin (BCG) scar is one of the characteristic findings of KD, and is useful for the diagnosis in countries where BCG vaccination is mandated in infancy. Furthermore, such findings in BCG scar were also reported after SARS-CoV-2 vaccination, which may be related to molecular mimicry. However, there are no reports of changes at the BCG scar in MIS-C cases. Here, we report a case of MIS-C in a 3-year-old Hispanic boy in Japan, with erythema and induration at the BCG scar. The patient received BCG vaccination at 16 months of age in Japan. Four weeks before the onset, he had positive polymerase chain reaction (PCR) results for SARS-CoV-2 following household outbreak, although he was asymptomatic. He presented with fever and gastrointestinal symptoms, followed by the appearance of all six principal findings of complete KD. He exhibited congestive heart failure, following intravenous immunoglobulin (IVIG) therapy. He was diagnosed with MIS-C based on characteristic mucocutaneous and gastrointestinal symptoms, decreased cardiac function, and coagulopathy, in addition to laboratory data consistent with MIS-C. The BCG finding was present from the early stage of the disease. The patient was refractory to two doses of IVIGs, and the third IVIG plus prednisolone resulted in defervescence and improvement in heart failure. No coronary involvement was observed. This is the first case of erythema and induration at the BCG scar associated with MIS-C accompanied by KD features, which may give clinical and mechanistic insights in the understanding of the disease. Since the full spectrum of MIS-C is still evolving and both of them are syndromes with overlapped clinical features, further studies are warranted for deep phenotyping of MIS-C with KD features relative to KD in countries with mandatory BCG programs in infancy.<\/jats:p>","DOI":"10.3389\/fped.2022.849473","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T09:35:27Z","timestamp":1646991327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Erythema and Induration of Bacillus Calmette-Gu\u00e9rin Scar Associated With Multisystem Inflammatory Syndrome in Children in Japan: A Case Report"],"prefix":"10.3389","volume":"10","author":[{"given":"Naoki","family":"Tsuboya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunobu","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Hanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Yodoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents.","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1016\/S1473-3099(20)30651-4","article-title":"COVID-19 and multisystem inflammatory syndrome in children and adolescents.","volume":"20","author":"Jiang","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s41591-020-1140-9","article-title":"The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges.","volume":"26","author":"Martinez","year":"2020","journal-title":"Nat Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41584-021-00709-9","article-title":"Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.","volume":"17","author":"Sharma","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144554","article-title":"Similarities and differences between the immunopathogenesis of COVID-19\u2013related pediatric multisystem inflammatory syndrome and Kawasaki disease.","volume":"131","author":"Esteve-Sole","year":"2021","journal-title":"J Clin Invest."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.30280","article-title":"Race\/ethnicity among children with COVID-19-associated multisystem inflammatory syndrome.","volume":"3","author":"Lee","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B7","year":"2021","journal-title":"COVID Data Tracker."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/cir.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American heart association.","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/INF.0b013e3181cacede","article-title":"Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Gu\u00e9rin inoculation site.","volume":"29","author":"Uehara","year":"2010","journal-title":"Pediatr Infect Dis J."},{"key":"B10","year":"2021","journal-title":"Status of L452R Mutant Strain Screening."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","article-title":"JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease.","volume":"84","author":"Fukazawa","year":"2020","journal-title":"Circ J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/circulationaha.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","article-title":"Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.","volume":"166","author":"Sano","year":"2007","journal-title":"Eur J Pediatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.","volume":"149","author":"Egami","year":"2006","journal-title":"J Pediatr."},{"key":"B15","year":"2020","journal-title":"Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19)."},{"key":"B16","year":"2020","journal-title":"Multisystem Inflammatory Syndrome in Children and Adolescents with COVID-19 Scientific Brief."},{"key":"B17","year":"2021","journal-title":"WHO Characterizes COVID19 as a Pandemic."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG world atlas: a database of global BCG vaccination policies and practices.","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tube.2009.03.002","article-title":"Mapping the global use of different BCG vaccine strains.","volume":"89","author":"Ritz","year":"2009","journal-title":"Tuberculosis (Edinb)."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012661","article-title":"Is BCG vaccination causally related to reduced COVID-19 mortality?","volume":"12","author":"Miyasaka","year":"2020","journal-title":"EMBO Mol Med."},{"key":"B21","year":"2019","journal-title":"Guidelines for the Diagnosis of Kawasaki Disease."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-019-1635-z","article-title":"Measles infection causing Bacillus Calmette-Gu\u00e9rin reactivation: a case report.","volume":"19","author":"Muthuvelu","year":"2019","journal-title":"BMC Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1620\/tjem.228.351","article-title":"Human herpes virus type 6 can cause skin lesions at the BCG inoculation site similar to Kawasaki disease.","volume":"228","author":"Kakisaka","year":"2012","journal-title":"Tohoku J Exp Med."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0390-2019","article-title":"Erythema at the Bacillus Calmette-Guerin scar after influenza vaccination.","volume":"53","author":"Chavarri-Guerra","year":"2019","journal-title":"Rev Soc Bras Med Trop."},{"key":"B25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0190-9622(97)80376-3","article-title":"An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease.","author":"Kuniyuki","year":"1997","journal-title":"J Am Acad Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/s0022-3476(06)80113-7","article-title":"Immunopathology and cytokine detection in the skin lesions of patients with Kawasaki disease.","volume":"122","author":"Sato","year":"1993","journal-title":"J Pediatr."},{"key":"B27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03401796","article-title":"T cells recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease.","volume":"6","author":"Sireci","year":"2000","journal-title":"Mol Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1006\/clin.1993.1060","article-title":"Presence in Kawasaki disease of antibodies to mycobacterial heat-shock protein HSP65 and autoantibodies to epitopes of human HSP65 cognate antigen.","volume":"67","author":"Yokota","year":"1993","journal-title":"Clin Immunol Immunopathol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14453","article-title":"BCG scar local skin inflammation as a novel reaction following mRNA COVID-19 vaccines in two international healthcare workers.","volume":"13","author":"Lopatynsky-Reyes","year":"2021","journal-title":"Cureus."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.210696","article-title":"Bacillus Calmette-Gu\u00e9rin scar flare after an mRNA SARS-CoV-2 vaccine.","volume":"193","author":"Lim","year":"2021","journal-title":"CMAJ."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06949-0","article-title":"Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports.","volume":"21","author":"Mohamed","year":"2021","journal-title":"BMC Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"151600","DOI":"10.1016\/j.anndiagpath.2020.151600","article-title":"Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.","volume":"48","author":"Nuovo","year":"2020","journal-title":"Ann Diag Pathol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.692729","article-title":"BCG vaccine derived peptides induce SARS-CoV-2 T cell cross-reactivity.","volume":"12","author":"Eggenhuizen","year":"2021","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/499825","article-title":"The effect of bacille Calmette-Gu\u00e9rin vaccine strain and route of administration on induced immune responses in vaccinated infants.","volume":"193","author":"Davids","year":"2006","journal-title":"J Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1128\/iai.00244-07","article-title":"Unique gene expression profiles in infants vaccinated with different strains of mycobacterium bovis bacille Calmette-Guerin.","volume":"75","author":"Wu","year":"2007","journal-title":"Infect Immun."},{"key":"B36","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/INF.0000000000001633","article-title":"Reaction of the BCG scar in the acute phase of Kawasaki disease in Mexican children.","volume":"36","author":"Garrido-Garc\u00eda","year":"2017","journal-title":"Pediatr Infect Dis J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.34297\/AJBSR.2020.09.001384","article-title":"First retrospective analysis of 448 pediatric cases of Kawasaki disease of two cohorts from China and Russia.","volume":"9","author":"Bakradze","year":"2020","journal-title":"Am J Biomed Sci Res."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.21542\/gcsp.2017.21","article-title":"The emergence of Kawasaki disease in India and China.","volume":"2017","author":"Jiao","year":"2017","journal-title":"Glob Cardiol Sci Pract."},{"key":"B39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.11622\/smedj.2018084","article-title":"Erythema and induration of the Bacillus Calmette-Gu\u00e9rin site for diagnosing Kawasaki disease.","volume":"60","author":"Loh","year":"2019","journal-title":"Singapore Med J."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.849473\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T09:35:32Z","timestamp":1646991332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.849473\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":39,"alternative-id":["10.3389\/fped.2022.849473"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.849473","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"article-number":"849473"}}